People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Arch Therapeutics, Inc. | — | Biotechnology | Series A | $26.0M | $58.0M | 2022 |
Daniel M. Yrigoyen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel M. Yrigoyen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Davis | 1 | 8 |
| Avtar Dhillon | 1 | 4 |
| Michael S Abrams | 1 | 3 |
| ALAN BARBER | 1 | 3 |
| Terrence W. Norchi | 1 | 2 |
| Richard E. Davis | 1 | 2 |
| Avtar W. Dhillon | 1 | 2 |
| ARTHUR W ROSENTHAL | 1 | 2 |
| William Cotter | 1 | 2 |
| Arthur Rosenthal | 1 | 2 |
| Punit W. Dhillon | 1 | 1 |
| Terrence Norchi | 1 | 1 |
| James R. Sulat | 1 | 1 |
| ALAN W BARBER | 1 | 1 |
| Norchi Terrence | 1 | 1 |
| Guy W. Fish | 1 | 1 |
| Laurence W. Hicks | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.